| Public | NYSE:MDT |
| Raised | |
| Post IPO Valuation |
| Website | medtronic.com |
| @Medtronic | |
| Category | BioTech |
| Phone | 763-514-4000 |
| Employees | |
| Founded | 1949 |
| Description | Treatment research for Chronic Diseases |
| Total | $800M |
| Salient Surgical Technologies, 7/11 | |
| PEAK Surgical, 7/11 | |
| Ardian, 1/11 | $800M |
| MC10 | 12/12 |
| Mitralign | 5/12 |
| AcuFocus | 11/11 |
| Functional Neuromodulation | 10/11 |
| PowerVision | 7/11 |
| Spinal Modulation | 6/11 |
| PhysioSonics | 5/11 |
| Intersect ENT | 11/10 |
| Salient Surgical Technologies | 1/10 |
| GI Dynamics | 1/10 |
| MicroCHIPS | 1/10 |
| CardioMEMS | 10/09 |
| NanoCor Therapeutics | 9/07 |
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.